SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-20-013197
Filing Date
2020-07-13
Accepted
2020-07-13 17:30:57
Documents
16

Document Format Files

Seq Description Document Type Size
1 forms-3a.htm S-3/A 459729
2 ex23-1.htm EX-23.1 3929
3 ex23-2.htm EX-23.2 4574
4 ex23-3.htm EX-23.3 5758
5 image_001.jpg GRAPHIC 10994
6 image_002.jpg GRAPHIC 19323
7 image_003.jpg GRAPHIC 21201
8 image_004.jpg GRAPHIC 25948
9 image_005.jpg GRAPHIC 32430
10 image_006.jpg GRAPHIC 27755
11 image_008.jpg GRAPHIC 29896
12 image_009.jpg GRAPHIC 34924
13 image_010.jpg GRAPHIC 28923
14 image_011.jpg GRAPHIC 21622
15 image_012.jpg GRAPHIC 16338
16 image_013.jpg GRAPHIC 93203
  Complete submission text file 0001493152-20-013197.txt   975760
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-237795 | Film No.: 201025894
SIC: 2834 Pharmaceutical Preparations